ArticlePloS one2013

CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.

Wenchang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.